{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:34:28Z","timestamp":1790865268422,"version":"4.1.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2283,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1002\/hep.22959","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T17:45:33Z","timestamp":1238435133000},"page":"2080-2086","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":90,"title":["Long\u2010term therapy with clevudine for chronic hepatitis B can be associated with myopathy characterized by depletion of mitochondrial DNA\u2020"],"prefix":"10.1097","volume":"49","author":[{"given":"Jung Im","family":"Seok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Kuck","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Hyeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Su","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyang\u2010Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee\u2010Young","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Hun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae\u2010Seong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-34-20241201","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1053\/gast.2000.8559","article-title":"Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B","volume":"119","author":"Liaw","year":"2000","journal-title":"Gastroenterology"},{"key":"R2-34-20241201","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1053\/jhep.2001.25084","article-title":"Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy","volume":"33","author":"Leung","year":"2001","journal-title":"HEPATOLOGY"},{"key":"R3-34-20241201","first-page":"350","article-title":"Current therapy with nucleoside\/nucleotide analogs for patients with chronic hepatitis B","volume":"5","author":"Xu","year":"2006","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R4-34-20241201","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S0140-6736(95)91829-9","article-title":"Hepatitis B reactivation after lamivudine","volume":"346","author":"Honkoop","year":"1995","journal-title":"Lancet"},{"key":"R5-34-20241201","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM199510263331702","article-title":"Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B","volume":"333","author":"McKenzie","year":"1995","journal-title":"N Engl J Med"},{"key":"R6-34-20241201","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/hep.21800","article-title":"Clevudine is highly efficacious in hepatitis B e antigen\u2010negative chronic hepatitis B with durable off\u2010therapy viral suppression","volume":"46","author":"Yoo","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R8-34-20241201","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0960-8966(99)00132-7","article-title":"Phenotypic manifestations associated with CAG\u2010repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families","volume":"10","author":"Mariotti","year":"2000","journal-title":"Neuromuscul Disord"},{"key":"R11-34-20241201","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"R12-34-20241201","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1128\/AAC.46.12.3854-3860.2002","article-title":"Antiviral activities and cellular toxicities of modified 2\u2032,3\u2032\u2010dideoxy\u20102\u2032,3\u2032\u2010didehydrocytidine analogues","volume":"46","author":"Stuyver","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"R13-34-20241201","doi-asserted-by":"crossref","first-page":"e893","DOI":"10.1371\/journal.pone.0000893","article-title":"The restriction of zoonotic PERV transmission by human APOBEC3G","volume":"2","author":"J\u00f3nsson","year":"2007","journal-title":"PLoS ONE"},{"key":"R14-34-20241201","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1586\/14787210.4.4.549","article-title":"Clevudine: a potent inhibitor of hepatitis B virus in vitro and in vivo","volume":"4","author":"Korba","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R15-34-20241201","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1053\/jhep.2001.20899","article-title":"Antiviral activity of clevudine [L\u2010FMAU, (1\u2010(2\u2010fluoro\u20105\u2010methyl\u2010beta, L\u2010arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax)","volume":"33","author":"Peek","year":"2001","journal-title":"HEPATOLOGY"},{"key":"R16-34-20241201","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00002281-199511000-00006","article-title":"Myopathy and HIV infection","volume":"7","author":"Chariot","year":"1995","journal-title":"Curr Opin Rheumatol"},{"key":"R17-34-20241201","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0022-510X(98)00151-8","article-title":"Clinical, histological and molecular reversibility of zidovudine myopathy","volume":"159","author":"Masan\u00e9s","year":"1998","journal-title":"J Neurol Sci"},{"key":"R18-34-20241201","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/01.RES.74.2.344","article-title":"Cardiac mitochondrial DNA polymerase\u2010gamma is inhibited competitively and noncompetitively by phosphorylated zidovudine","volume":"74","author":"Lewis","year":"1994","journal-title":"Circ Res"},{"key":"R19-34-20241201","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nrd1201","article-title":"Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective","volume":"2","author":"Lewis","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"R21-34-20241201","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1399-3046.2007.00839.x","article-title":"Renal Fanconi syndrome and myopathy after liver transplantation: drug\u2010related mitochondrial cytopathy?","volume":"12","author":"Bayrakci","year":"2008","journal-title":"Pediatr Transplant"},{"key":"R22-34-20241201","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1056\/NEJMoa066422","article-title":"Telbivudine versus lamivudine in patients with chronic hepatitis B","volume":"357","author":"Lai","year":"2007","journal-title":"N Engl J Med"},{"key":"R23-34-20241201","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1600-6143.2005.00691.x","article-title":"Rhabdomyolysis due to lamivudine administration in a liver transplant recipient","volume":"5","author":"Adani","year":"2005","journal-title":"Am J Transplant"},{"key":"R24-34-20241201","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/jlts.2002.36734","article-title":"Rhabdomyolytic syndrome during the lamivudine therapy for acute exacerbation of chronic type B hepatitis","volume":"8","author":"Yahagi","year":"2002","journal-title":"Liver Transpl"},{"key":"R25-34-20241201","first-page":"487","article-title":"Mitochondrial and cellular toxicity induced by fialuridine in human muscle in vitro","volume":"76","author":"Semino\u2010Mora","year":"1997","journal-title":"Lab Invest"},{"key":"R26-34-20241201","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1128\/AAC.40.2.380","article-title":"Inhibition of hepatitis B virus by a novel L\u2010nucleoside, 2\u2032\u2010fluoro\u20105\u2010methyl\u2010\u03b2\u2010L\u2010arabinofuranosyluracil","volume":"40","author":"Pai","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"R27-34-20241201","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0149-2918(00)90004-3","article-title":"Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor\u2010induced mitochondrial toxicity","volume":"22","author":"Kakuda","year":"2000","journal-title":"Clin Ther"},{"key":"R28-34-20241201","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000134943","article-title":"Mechanisms of zidovudine\u2010induced mitochondrial toxicity and myopathy","volume":"82","author":"Scruggs","year":"2008","journal-title":"Pharmacology"},{"key":"R29-34-20241201","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/01.wnl.0000240078.47020.5e","article-title":"The association of chronic hepatitis B and myopathy","volume":"67","author":"Capasso","year":"2006","journal-title":"Neurology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.22959","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200906000-00034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T13:14:48Z","timestamp":1733058888000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200906000-00034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.22959","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}